TSX : APLI.TO

Appili Therapeutics Inc.

$0.015 CAD

$0 (0.0%)

Volume
0
Average Volume
55.21K
Market Capitalization
$1.99M
P/E Ratio
-0.44
Dividend Yield
0.00%
Price Target
Year High
$0.04
Year Low
$0.01
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$0.11
Company Overview

TSX

Donald D. Cilla Jr. Pharmd

Biotechnology

Healthcare

APLI.TO

7

CA

CAD

https://www.appilitherapeutics.com

902 442 4655

03783R107

N/A

Liquidity Metrics

-0.75

0.11

0.11

0.00

0.00

Sales & Valuation

$244.18K

7.61

-0.11

-1.50

-0.01

Profitability

-$0.0343

-$4.24M

-1622.17%

-1577.48%

26.47%

-214.47%

P/E Metrics

-0.44

0.01

0.01

Analyst Price Target & Rating

Sell

2/5

0 Analysts

%

Poll Results

About Appili Therapeutics Inc. (TSX:APLI.TO) Stock

Appili Therapeutics Inc., a Canadian biopharmaceutical firm headquartered in Halifax and founded in 2015, specializes in sourcing and advancing innovative treatments to address critical gaps in infectious disease medicine. The company's diverse pipeline includes Favipiravir, utilized for pandemic influenza and COVID-19, and the clinical-stage antifungal ATI-2307, which targets cryptococcal meningitis and invasive candidiasis. Other programs feature ATI-1503, a new class of gram-negative targeting antibiotics; ATI-1501, a taste-masked liquid oral metronidazole suspension; ATI-1801, a novel topical formulation of paromomycin for treating cutaneous leishmaniasis; and ATI-1701, a live-attenuated vaccine designed for Francisella tularensis. Additionally, Appili maintains a strategic collaborati ... on with AiPharma Global Holdings LLC for the ongoing development of Avigan/Reeqonus (favipiravir).

Frequently Asked Questions

What is the current Appili Therapeutics Inc. (APLI.TO) stock price?

Appili Therapeutics Inc.(TSX:APLI.TO) stock price is $0.015 in the last trading session. During the trading session, APLI.TO stock reached the peak price of $0.04 while $0.01 was the lowest point it dropped to. The percentage change in APLI.TO stock occurred in the recent session was 0.0% while the dollar amount for the price change in APLI.TO stock was $0.

APLI.TO's industry and sector of operation?

The TSX listed APLI.TO is part of Biotechnology industry that operates in the broader Healthcare sector.

Who are the executives of APLI.TO?

Kenneth G. Howling | Acting Chief Financial Officer
Gary S. Nabors | Chief Development Officer
Carl Gelhaus | Director of Non-Clinical Research
Donald D. Cilla Jr. Pharmd | Chief Executive Officer, President & Director
Jenna McNeil | Corporate Affairs & Communications Manager

How many employees does APLI.TO have?

Number of APLI.TO employees currently stands at 7. APLI.TO operates from #21-1344 Summer Street, Halifax, NS B3H 0A8, CA.

Link for APLI.TO official website?

Official Website of APLI.TO is: https://www.appilitherapeutics.com

How do I contact APLI.TO?

APLI.TO could be contacted at phone #902 442 4655 and can also be accessed through its website. APLI.TO operates from #21-1344 Summer Street, Halifax, NS B3H 0A8, CA.

How many shares of APLI.TO are traded daily?

The average number of APLI.TO shares traded daily for last 3 months was 55.21K.

What is the market cap of APLI.TO currently?

The market value of APLI.TO currently stands at $1.99M with its latest stock price at $0.015